SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
shenlu
Lv1
100 积分
2022-03-03 加入
最近求助
最近应助
互助留言
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
12天前
已完结
Lung adenocarcinoma with sarcomatoid transformation after tyrosine kinase inhibitor treatment and chemotherapy
1个月前
已完结
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
1个月前
已完结
Circulating Tumor DNA Dynamics as Prognostic Markers in Locally Advanced and Metastatic Esophageal Squamous Cell Carcinoma
1个月前
已完结
Urinary Tumor DNA MRD Analysis to Identify Responders to Neoadjuvant Immunotherapy in Muscle-invasive Bladder Cancer
1个月前
已完结
Monitoring Treatment Response and Metastatic Relapse in Advanced Bladder Cancer by Liquid Biopsy Analysis
1个月前
已完结
Genomic characterization of metastatic breast cancers
3个月前
已完结
Immunotherapies for hepatocellular carcinoma
3个月前
已完结
Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-Label, Phase 2 Trial (Cohort 4)
5个月前
已完结
The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272
5个月前
已完结
没有进行任何应助
寻求的文章是发表在lung cancer杂志上
1个月前
求助的是附件,谢谢!
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论